MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 203 filers reported holding MYRIAD GENETICS INC in Q2 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,517,464 | -9.5% | 108,605 | -9.3% | 0.01% | -10.0% |
| Q1 2023 | $2,782,002 | +60.1% | 119,759 | 0.0% | 0.01% | +42.9% |
| Q4 2022 | $1,737,703 | -9.0% | 119,759 | +19.6% | 0.01% | -12.5% |
| Q3 2022 | $1,910,000 | +5.0% | 100,094 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $1,819,000 | -27.9% | 100,094 | 0.0% | 0.01% | -12.5% |
| Q1 2022 | $2,522,000 | -8.7% | 100,094 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $2,763,000 | +10.1% | 100,094 | +28.8% | 0.01% | 0.0% |
| Q3 2021 | $2,509,000 | -9.8% | 77,688 | -14.6% | 0.01% | -11.1% |
| Q2 2021 | $2,781,000 | +7.3% | 90,941 | +6.9% | 0.01% | 0.0% |
| Q1 2021 | $2,591,000 | +72.7% | 85,096 | -35.7% | 0.01% | +50.0% |
| Q2 2020 | $1,500,000 | +12.1% | 132,244 | +41.4% | 0.01% | 0.0% |
| Q1 2020 | $1,338,000 | -47.4% | 93,499 | 0.0% | 0.01% | -40.0% |
| Q4 2019 | $2,546,000 | -0.5% | 93,499 | +4.6% | 0.01% | 0.0% |
| Q3 2019 | $2,560,000 | – | 89,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 6,635,000 | $106,425 | 3.51% |
| Glenview Capital Management | 3,783,982 | $60,695,071 | 1.37% |
| AMH Equity Ltd | 47,285 | $758,451 | 0.83% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,973,312 | $31,651,924 | 0.75% |
| EARNEST PARTNERS LLC | 3,473,281 | $55,711,427 | 0.32% |
| AIMZ Investment Advisors, LLC | 40,985 | $657,399 | 0.29% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 280,767 | $4,503,503 | 0.13% |
| Beverly Hills Private Wealth, LLC | 19,687 | $315,779 | 0.09% |
| Artisan Partners Limited Partnership | 2,537,147 | $40,695,838 | 0.07% |
| Jump Financial, LLC | 84,924 | $1,362,181 | 0.05% |